Advances in CAR-T cancer therapy & carbon materials' hidden defects | The chemical breakdown podcast
This week, we discuss a study showing promise in applying CAR-T immunotherapy in bladder cancer tumours and breakdown how scientists have uncovered spectral signatures previously misassigned in carbon materials – with Frankie Macpherson and Mason Wakley.
CAR-T therapy has been a game changer for blood cancers, yet solid tumours have been largely resistant to this treatment. We discuss a new study that shows promise in applying this immunotherapy in bladder cancer tumours.
And, we discuss why scientists are rethinking how they assign peaks in spectra of carbon-based materials. What does this mean for the technologies that rely on them, and do we need to rethink some long-held assumptions?
Main stories:
Headlines:
More description
This week, we discuss a study showing promise in applying CAR-T immunotherapy in bladder cancer tumours and breakdown how scientists have uncovered spectral signatures previously misassigned in carbon materials – with Frankie Macpherson and Mason Wakley.
CAR-T therapy has been a game changer for blood cancers, yet solid tumours have been largely resistant to this treatment. We discuss a new study that shows promise in applying this immunotherapy in bladder cancer tumours.
And, we discuss why scientists are rethinking how they assign peaks in spectra of carbon-based materials. What does this mean for the technologies that rely on them, and do we need to rethink some long-held assumptions?
Main stories:
Headlines:
Listen elsewhere
Available Results
Generated results are saved to your library for reuse and search.